Alpha Biomed Peptides Lab Scam?🚩
- ScamWatching.Org
- 24 hours ago
- 9 min read
 |
COMPLETE SCAM WATCHING REPORT |
Company Details: Alpha Biomed
Entity: Alpha BioMed Labs / Alpha BioMed Industries LLC
Website: https://alphabiomedlabs.com
Parent LLC: Alpha Biomed LLC (Registered California Aug 27 2024) Entity #202463613310
Registered Agent: Kaveh Newmen, 2107 N Broadway Suite 104, Santa Ana, CA 92706
Principal Address: 200 Spectrum Center Dr., Irvine, CA 92618
Phone: (888) 890-8143
CEO / Owner: Trevor Kruder (LinkedIn lists CEO of Alpha BioMed Industries, Paramount Peptides, Alpha BioMed Labs)
Trademark Applications: ALPHA BIOMED (Serial Nos. 98762857 & 98762885) — filed Sept 2024 under Alpha BioMed Industries LLC
Employees (LinkedIn): 11 – 50 listed
Social Media:
Facebook: Alpha BioMed Labs (https://www.facebook.com/AlphaBioMedLabs/)
YouTube: @AlphaBioMed (https://www.youtube.com/@AlphaBioMed)
TikTok: alphabiomedlabs (https://www.tiktok.com/@alphabiomedlabs)
Scam Score
A 1-star rating represents the lowest tier in our trust scale and signals high probability of deception, non-compliance, or consumer harm. Vendors in this category exhibit one or more of the following:
Verified false or misleading claims about origin, purity, or manufacturing.
Unverifiable lab documents (missing accreditation, self-issued, or forged).
Violations of federal or platform policies (FDA, FTC, Shopify, Stripe, etc.).
Mismatch between corporate filings, claimed experience, and public data.
Evidence of dosing/reconstitution instructions implying human use despite “research only” disclaimers.
Impact:
This low of a trust score automatically places the entity on ScamWatching.org red-flag status 🚩— meaning the brand is considered untrustworthy until independently verified. Listings under this score are recommended for public exposure, platform reporting, and community alerting.
Alpha BioMed Peptides GENERAL OVERVIEW
Alpha BioMed Labs presents itself as a “USA-based manufacturer and supplier of 99%+ pure peptides.” They emphasize “laboratories in the USA,” yet no public GMP registration or FDA establishment data exists. A “Greenville, SC campus” is mentioned for R&D and sterile vialing, but no address or license is publicly verifiable. They explicitly state they are not a 503A or 503B pharmacy, placing them in the “research use only” category while making therapeutic claims on SKU pages.
SUMMARY ASSESSMENT
Alpha BioMed Labs is a recently formed Shopify-hosted vendor posing as a long-standing U.S. manufacturer. Its public materials contain dosing and therapeutic language that violates both FDA advertising standards and Shopify/Stripe policy. COAs are provided by a notorious Chinese supporting testing lab and the Vials are clear like Chinese venders. Operational addresses in Irvine and Greenville appear front-office only. The evidence points to an American front built on a Chinese supply chain. There is nothing USA about this company other than it's branding.
Primary risk vectors: regulatory exposure, payment processor lockout, and platform suspension. This makes them high-vulnerability for public audit and reporting campaigns.
Platform Violation: Shopify AUP prohibits prescription drugs and research chemicals. Use of Shopify Payments (Stripe) compounds risk.
Regulatory Risk: Not FDA registered for manufacturing or repackaging drugs. Claims of “99% purity” and therapeutic effects qualify as drug claims under FDA/FTC guidelines.
Timeline Inconsistency: LLC formed Aug 2024 but claims “over ten years of experience.
Misleading Origins: “USA labs” claim vs. unverified Greenville and Irvine locations creates potential false advertising exposure.
PRODUCTS AND CLAIMS
Offerings: Full range of peptides (BPC-157, TB-500, GLP-1s, Selank, Semax, Tesamorelin, GHRP, Ipamorelin, HCG, etc.).
Claim language: Therapeutic statements appear on each page (“accelerates healing,” “enhances memory,” “improves metabolism”).
Dosing Guides: Public “Dosing Guide” page exists; providers’ portal lists “Dosing Calculators.”
A clinic-linked PDF titled “Peptide Ratios and Mixdowns – Alpha BioMed” contains mg/mL conversion tables and subQ/IM mix instructions — clear evidence of human-use guidance.
Reconstitution Info: Indirectly present in the mix-ratio guide.
Purity Claims: All SKUs advertise ≥ 99% purity from foreign testing that China uses.
DIGITAL FOOTPRINT
Platform: Shopify (Refresh theme v15.x, Shopify Payments likely active).
Hosting: Shopify servers behind Cloudflare CDN.
Checkout: Shopify standard cart and tax language detected (“Shopify does not allow tax refunds”).
Payment Risk: Shopify and Stripe both ban peptides and research chemicals in their AUPs — their merchant account is at imminent risk of suspension.
Domains/Subdomains: providers.alphabiomedlabs.com | partners.alphabiomedlabs.com | alphabiomedlabs.com.
VIOLATIONS AND RED FLAGS
They repeatedly invoke “our laboratories” and “USA manufactured peptides,” but provide no FDA registration numbers, no GMP/ISO-17025 certificates, and no facility addresses. FDA’s device/lab database doesn’t show an obvious match for an “Alpha BioMed” at that Irvine address. That absence plus the anonymous “1M+ vials” claim is a red-flag combo. Alpha BioMed
Dosing and Medical Claims:
A public PDF titled “Dosing Guide — Alpha BioMed” lives offsite and literally references their dosing page URL and Irvine address/phone. It includes titration schedules and unit conversions for Semaglutide and other peptides, e.g. “TITRATE UP FROM 250 MCG TO 2.5 MG, 1x per week,” and on PT-141 “AS NEEDED (2 hours before sexual activity).” That’s drug labeling. Not “research only.” Drug. Source: Dosing Guide-Alpha Biomed
Why that’s a legal problem:
FDA has been slapping peptide sellers precisely for this: claims and dosing reveal intended use as human drugs, rendering them unapproved new drugs and misbranded. See FDA warning letters against peptide vendors for GLP-1 analogs and others; the pattern is identical. U.S. Food and Drug Administration+2U.S. Food and Drug Administration+2
Their BPC-157 (10mg) page claims “accelerate the healing of muscles, tendons, ligaments… GI tract,” “reduce inflammation,” “protecting the gut lining… IBD.” Those are disease and structure/function claims for a substance with no FDA approval. Source: Alpha BioMed
BPC-157 is not FDA-approved; FDA lists it as a risky Category 2 bulk substance for compounding, and federal and sports bodies flag it as an unapproved drug. Selling it with therapeutic claims is classic “unapproved and misbranded drug” territory.
GLP-1 claims: Their site banners push GLP-1s; FDA has recently issued waves of letters to peptide sites selling unapproved Semaglutide/Tirzepatide online. Again: same pattern, same violations. Source: Alpha BioMed
Company filings tying Alpha Biomed LLC/Industries to the Irvine address on the dosing document and site.
Source: Bizprofile
Alpha Biomed Peptides has no GMP certs, no FDA registration posted despite “state-of-the-art laboratories” claims. Alpha BioMed
COA found with discrepancies:
On the product page of Thymosin Beta 4 (TB500) 10 mg (10 mg vial) on the “Alpha BioMed” site, the description nominally says “Thymosin Beta 4 (TB500) (10mg) …” and markets wound healing, inflammation reduction, sports recovery. Alpha BioMed
In the screenshot provided below (and linked visuals), there’s a Test Report (“Janoshik Test Report”) image listing Sample: “TB4/BPC-157 Blend” with Batch BPC10N061125 (or similar) and specification lines showing BPC-157 ~11 mg and TB-500 ~10 mg. So it says “TB4/BPC-157 Blend” but the product label said “BPC-157 / TB500” (or maybe “TB-500/BPC-157”). That mismatch “TB4 vs TB500” is notable.
From credible research sources:
TB-500 is a synthetic analog of full length TB4 (thymosin beta-4). Peptide Sciences
They are different peptides (different lengths, activity, regulatory status). For example, TB4 is full peptide of ~43 amino acids; TB-500 is a fragment (~7 amino acids) derived to mimic TB4. Peptide Sciences
This clearly shows that Alpha Biomed Peptides does not know the difference and do not understand the Peptides that they are selling. Also, the dosages are typically different for the fragment vs. the full chain.
If COA doesn’t match product label, then what exactly was shipped?
Mislabeling or inconsistent naming between product label and test report suggests either sloppy manufacturing/documentation or intentional obfuscation. Either way: risk.
For regulatory enforcement: If a company sells “TB-500” but the COA/test says “TB4” (or vice versa), then the product is not accurately described. That can trigger misbranding issues under the FD&C Act (a drug must be labeled and tested as described).
For consumer safety: They imply the compound is a known entity (“TB-500”) but their test certificate references a different molecule (“TB4”), which undermines traceability, testing validity, consistency of what the buyer gets.
This mismatch is a piece of the narrative that the site is not manufacturing with full control or transparency, raising further red flags around sterile manufacturing claims, COA authenticity, etc.
They sell bacteriostatic “Reconstitution Solution” explicitly “for injection,” beside peptide SKUs.
“sterile… safe for injection… ideal for reconstituting peptides that require multiple doses… administration of peptides like GHRPs.” This pairs their powders with an injectable solvent and use-case. It screams intended human use. Alpha BioMed
FDA’s warnings on unapproved GLP-1 sellers note that instructions and materials enabling dosing evidence intended use as drugs. U.S. Food and Drug Administration
Social accounts look fake/dead
Footer links to Facebook/Instagram/TikTok/YouTube are present, but the Facebook and Instagram endpoints don’t resolve in a normal way and appear abandoned or removed, which matches the screenshots of a dead FB page and a removed IG account. The broken links are visible across the site footer. Alpha BioMed
Since their social accounts on their main website were banned, they created a new account in October 2025 and pumped it with fake Instagram accounts to make it look real.
Alpha Biomed Peptides first post after their original Instagram has been banned:
Alpha BioMed’s deceptive professional framing and structural compliance flaw.
On their website for providers multiple blocks show duplicative widgets and “Best Sellers” repeats rather than organic reviews. I didn’t find verifiable review provenance or unique per-SKU review counts. The site structure screams prefab theme with placeholders swapped in late. Source: Alpha BioMed
Lets breakdown their "Provider's Intake Form"
Regulatory Misrepresentation
They market “provider-only” access, which implies DEA, FDA, or at least state-level verification of medical credentials. But their intake form lets anyone bypass those checkpoints by clicking “Not sure.” That means they’re pretending to operate in a restricted-access model without enforcing it.
Angle: It’s a textbook example of false gatekeeping — giving the illusion of regulation to look legitimate while quietly opening the floodgates for unlicensed buyers.
Improper Data Collection
They request EIN, NPI, and tax exemption documents while not verifying any of them. That’s sensitive, government-issued data — yet they have no stated process for credential validation or secure storage.
Angle: They’re harvesting federally linked identifiers without a compliance framework. That alone could violate FTC Section 5 (unfair/deceptive acts) and HIPAA-adjacent data handling expectations if health providers are involved.
Privacy Policy Conflict
their April 2025 “policy” is boilerplate Shopify junk. It admits to “selling/sharing personal identifiers for marketing.”
That creates a fatal contradiction: they collect EINs and NPIs under the guise of professional verification, then use a privacy policy that allows reselling of identifiers.
Angle: They’re effectively building a marketing list of verified-sounding “providers” to resell, while pretending it’s a compliance portal.
Potential Fallout for Businesses
By entering EIN or NPI data into that form, a business risks:
Identity fraud (those numbers can be used to open supplier accounts)
Tax fraud exposure (false filings or resale misrepresentation)
Marketing spam / resale (since the policy admits data sharing)
Regulatory investigation if Alpha BioMed uses that data to make provider claims
Discrepancies in Alpha BioMed’s Contact Information between their 'Providers' Website and Main Website
The two numbers: one is (888) 890-8143 (main site). The provider's website shows (949) 867-6165.
Two different toll-free / area codes. That mismatch creates trust issues.
Multiple links (main site and portal) both claim to be “official,” but have different contact info. That’s sloppy or intentionally ambiguous.
If the portal uses area code 949 (Southern California) rather than toll-free 888, that could indicate a separate (or sub-contracted) line. If they don’t clearly explain that difference, it weakens their claim of a singular coherent operation.
Pattern of Risk and Regulatory Evasion
The investigation into Alpha BioMed Labs reveals a pattern consistent with deceptive marketing practices and potential regulatory violations. Although the company presents itself as a “U.S.-based manufacturer” of pharmaceutical-grade peptides, the evidence tells a different story: inconsistent contact details, unverifiable manufacturing claims, and public dosing instructions for substances that are not FDA-approved.
The firm’s dual website infrastructure — split between a retail-facing Shopify storefront and a “provider-only” registration portal — allows consumers to access and purchase peptides with minimal verification. Features such as the “Not Sure” option on reseller applications, the public release of dosing and reconstitution guides, and frequent therapeutic claims (“accelerates healing,” “improves metabolism”) indicate that Alpha BioMed is intentionally marketing unapproved drugs under the guise of “research chemicals.”
Furthermore, the absence of verifiable FDA registration, lack of ISO or GMP certifications, inconsistent COA documentation, and reliance on Shopify Payments (which prohibits such products) highlight systemic noncompliance. Even the mismatched phone numbers, recycled templates, and unverifiable test reports point toward an operation optimized for sales rather than safety or transparency.
In short, Alpha BioMed Labs exemplifies the growing class of online “research peptide” vendors that blur the line between laboratory use and human application. The inconsistencies and violations outlined in this report merit closer scrutiny by regulators, payment processors, and consumers alike. Until verifiable documentation and compliance measures are produced, Alpha BioMed’s operations should be treated as high-risk and potentially misleading within the health and biotech marketplace.
FDA Crackdown: Three Peptide Companies Cited for the Same Violations Seen at Alpha BioMed
Here are the top 3 companies that has been cited for the same violations seen at Alpha BioMed
Prime Vitality, Inc. (dba Prime Peptides) | WARNING LETTER 695156 (Dec 10, 2024) Direct link to Warning letter: U.S. Food and Drug Administration | Despite labeling “for research purposes only,” the site’s content showed intended human use/disease treatment language. Violation: unapproved new drugs under FD&C Act. |
Summit Research Peptides | WARNING LETTER 695607 (Dec 10, 2024) Direct link to warning letter: U.S. Food and Drug Administration | The FDA found that despite “research only” labeling, the evidence showed they intended human use. |
Xcel Research LLC | WARNING LETTER 695156 (Dec 10, 2024) Direct link to Warning letter: U.S. Food and Drug Administration | Violated 505(a) & 301(d) of FD&C Act for unapproved new drugs. |
Prime Vitality, Inc. (dba Prime Peptides) Warning Letter Highlighting their Violations:
Summit Research Peptides Warning Letter Highlighting Their Violations:
Xcel Research LLC Warning Letter Highlighting their Violations:
All findings and supporting evidence referenced in this report are sourced from publicly available records. Any attempt to alter or remove such material may constitute interference with public documentation and will be noted for compliance review.
Individuals who have experienced deceptive or unauthorized practices involving Alpha BioMed Labs are encouraged to file a report using our intake form for review and documentation. Submissions may be evaluated for potential escalation to a coordinated consumer complaint or class action proceeding if sufficient evidence is established.
Comments